3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
77
Myelodysplastic Syndromes
20
Leukemia, Myelomonocytic, Chronic
11
Myeloproliferative Disorders
6
Hematologic Neoplasms
5
Anemia, Refractory, with Excess of Blasts
4
Recurrence
3
Neoplasms
3
Myelodysplastic-Myeloproliferative Diseases
3
Leukemia
3
Hematologic Diseases
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
GATA2 Deficiency
2
Sarcoma, Myeloid
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pathologic Complete Response
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Interventions
Specimen Handling
52
Carboplatin
49
pembrolizumab
45
Magnetic Resonance Spectroscopy
44
Pemetrexed
39
Cisplatin
34
Paclitaxel
24
durvalumab
23
osimertinib
20
Nivolumab
19
Gemcitabine
19
Radiosurgery
17
Docetaxel
17
atezolizumab
15
Taxes
12
Radiotherapy
12
Immunoglobulin G
12
Disulfides
12
Biopsy
12
130-nm albumin-bound paclitaxel
12
Etoposide
11
Educational Status
11
Radiation
10
Drug Therapy
10
Blood Specimen Collection
10
Platinum
9
Early Intervention, Educational
9
Cetuximab
9
Methods
8
Bevacizumab
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Azacitidine
×
90 days
×
Clear all
No trials found.